Synapse - Works

Results (116512)

MGTA-117, an anti-CD117 antibody-drug conjugated with amanitin, in participants with relapsed/refractory adult acute myeloid leukemia (AML) and myelodysplasia with excess blasts (MDS-EB): Safety, pharmacokinetics and pharmacodynamics initial findings from a phase 1/2 study

Meeting Abstract

Westervelt, P.; Kebriaei, P.; Juckett, M.; Artz, A. S.; Chan, O.; McCarthy, P. L.; Farag, S. S.; Singh, A. K.; Stein, E.; Humphrey, J.; more...
Blood (2022)

Fulltext@MSK | Save

Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures

Meeting Abstract

Ziccheddu, B.; Diamond, B.; Maclachlan, K. H.; Taylor, J.; Boyle, E. M.; Arango Ossa, J. E.; Jacob, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
Blood (2022)

Fulltext@MSK | Save

Treatment of individuals with severe sickle cell disease with OTQ923, an autologous, ex vivo, CRISPR/Cas9-edited, CD34+ hematopoietic stem and progenitor cell product, leads to durable engraftment and fetal hemoglobin induction

Meeting Abstract

Sharma, A.; Boelens, J. J.; Cancio, M. I.; Hankins, J.; Bhad, P. A.; Lewandowski, A.; Zhao, X.; Chitnis, S.; Peddinti, R.; Zheng, Y.; more...
Blood (2022)

Fulltext@MSK | Save

Patient-derived iPSCs faithfully represent the genetic diversity and cellular architecture of human acute myeloid leukemia

Meeting Abstract

Cruz-Rodriguez, N.; Kotini, A. G.; Carcamo, S.; Olszewska, M.; Bernard, E.; Luo, H.; Kharas, M. G.; Hasson, D.; Papapetrou, E. P.
Blood (2022)

Fulltext@MSK | Save

A risk-adapted study to assess the efficacy of enasidenib and subsequent response-driven addition of azacitidine for newly diagnosed IDH2-mutant AML patients: 3-year follow-up

Meeting Abstract

Stein, E.; Cai, S. F.; Huang, Y.; Dunbar, A.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W. G.; Schiller, G. J.; Olin, R. L.; more...
Blood (2022)

Fulltext@MSK | Save

Multicenter phase I study of post-transplant low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia

Meeting Abstract

Metheny, L.; Sobecks, R. M.; Cho, C.; Wang, J.; Ciarrone, L.; Caimi, P. F.; Otegbeye, F.; Cooper, B. W.; Gallogly, M.; Malek, E.; more...
Blood (2022)

Fulltext@MSK | Save

Kinase dead BTK mutations confer resistance to covalent and noncovalent BTK inhibitors but are susceptible to clinical stage BTK degraders

Meeting Abstract

Montoya, S.; Bourcier, J.; Thompson, M. C.; Noviski, M.; Tan, M.; Wang, E.; Mi, X.; Brathaban, N.; Risso, C. B.; Tsai, D.; more...
Blood (2022)

Fulltext@MSK | Save

Observational cohort study of people living with HIV (PWH) treated with CD19-directed CAR T cell therapy for B-cell lymphoid malignancies - Interim results of AIDS Malignancy Consortium (AMC) study AMC-113

Meeting Abstract

Barta, S. K.; Noy, A.; Pasquini, M. C.; He, N.; Hunt, T.; Litovich, C.; Ibrahim, U.; Baiocchi, R. A.; Ambinder, R. F.
Blood (2022)

Fulltext@MSK | Save

Carfilzomib, lenalidomide and dexamethasone (KRd) vs bortezomib, lenalidomide, and dexamethasone (VRd) as induction therapy in newly diagnosed high-risk multiple myeloma

Meeting Abstract

Tan, C.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Patel, D.; Maclachlan, K. H.; Lahoud, O. B.; more...
Blood (2022)

Fulltext@MSK | Save

DNA methylation-based Burkitt Lymphoma epitypes have distinct molecular and clinical features

Meeting Abstract

Thomas, N.; Dreval, K.; Gerhard, D. S.; Hilton, L. K.; Abramson, J. S.; Bartlett, N. L.; Bethony, J.; Bowen, J.; Bryan, A.; Casper, C.; more...
Blood (2022)

Fulltext@MSK | Save